Abstract
唐仁海,叶润华,杨跃诚,姚仕堂,王继宝,张荣明,罗玲芳,吴正龙,龙玉存,尹棉松,何纳,段松.云南省德宏傣族景颇族自治州HIV感染的注射吸毒者未接受美沙酮维持治疗现况调查[J].Chinese journal of Epidemiology,2017,38(3):336-340
云南省德宏傣族景颇族自治州HIV感染的注射吸毒者未接受美沙酮维持治疗现况调查
A cross-sectional survey of receiving no methadone maintenance treatment in HIV infected injecting drug users in Dehong Dai and Jingpo autonomous prefecture, Yunnan province
Received:August 02, 2016  
DOI:10.3760/cma.j.issn.0254-6450.2017.03.012
KeyWord: 艾滋病  注射吸毒者  美沙酮维持治疗
English Key Word: AIDS  Injecting drug user  Methadone maintenance treatment
FundProject:国家重点地区艾滋病防治项目;国家科技重大专项(2013ZX10004-906);国家自然科学基金(81373062)
Author NameAffiliationE-mail
Tang Renhai Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China  
Ye Runhua Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China  
Yang Yuecheng Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China  
Yao Shitang Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China  
Wang Jibao Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China  
Zhang Rongming Mangshi County Center for Disease Control and Prevention, Mangshi 678400, China  
Luo Lingfang Yingjiang County Center for Disease Control and Prevention, Yingjiang 679300, China  
Wu Zhenglong Ruili County Center for Disease Control and Prevention, Ruili 678600, China  
Long Yucun Longchuan County Center for Disease Control and Prevention, Longchuan 678700, China  
Yin Miansong Lianghe County Center for Disease Control and Prevention, Lianghe 679200, China  
He Na Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China nhe@shmu.edu.cn 
Duan Song Dehong Prefecture Center for Disease Control and Prevention, Mangshi 678400, China dhduansong@sina.com.cn 
Hits: 3677
Download times: 1669
Abstract:
      目的 了解云南省德宏傣族景颇族自治州(德宏州)HIV感染的注射吸毒者(IDUs)未参加美沙酮维持治疗(MMT)情况及其相关因素。方法 从中国疾病预防控制信息系统艾滋病综合防治信息系统中下载2014年12月德宏州现存活的经注射吸毒传播的HIV/AIDS数据并开展专题调查,分析未参加MMT的比例及相关因素,并对其未参加MMT的原因进行分析。结果 德宏州应参加MMT的HIV感染的IDUs共987例,以男性、35~44岁、农民为主,分别占94.6%(934/987)、53.0%(523/987)、77.2%(762/987),未参加MMT的比例为60.0%(592/987)。多因素logistic回归分析显示,女性(OR=2.66,95% CI:1.21~5.87)、景颇族(OR=3.05,95% CI:1.97~4.71)等是未参加MMT的危险因素;非农民职业(OR=0.46,95% CI:0.31~0.70)、傣族(OR=0.53,95% CI:0.36~0.79)、确证感染时间≥10年(OR=0.60,95% CI:0.45~0.81)等是未参加MMT的保护因素。未参加MMT的原因包括路程远289人(48.8%)、怕暴露124人(20.9%)、不能坚持每天服药59人(10.0%)、担心副作用47人(7.9%)、其他73人(12.3%)。结论 德宏州HIV感染的IDUs中未参加MMT的比例高,女性、农民、景颇族、文化程度低、确证感染时间短等均是未参加MMT的影响因素,需采取针对性干预措施,进一步提高HIV感染的IDUs的MMT入组率。
English Abstract:
      Objective To understand the current status of receiving no methadone maintenance treatment (MMT) and influencing factors in HIV infected injecting drug users (IDUs) in Dehong Dai and Jingpo autonomous prefectures, Yunnan province. Methods Data of survival of IDUs with AIDS in Dehong were collected from "Chinese National Comprehensive HIV/AIDS and Care Information System" in December, 2014. Results There were 987 IDUs who should receive MMT, the majority of them were males (94.6%, 934/987), aged 35-44 years (53.0%, 523/987) and farmers (77.2%, 762/987). Among the 987 IDUs, 60.2% (592/987) received no MMT. Multivariate logistic regression analysis showed that being female (OR=2.66, 95%CI:1.21-5.87), in Jingpo ethnic group (OR=3.05, 95%CI:1.97-4.71) were the major risk factors for receiving no MMT; not being farmers (OR=0.46, 95%CI:0.31-0.70), in Dai ethnic group (OR=0.53, 95%CI:0.36-0.79), diagnosed HIV infection history ≥ 10 years (OR=0.60, 95%CI:0.45-0.81) were the major protective factors for receiving no MMT. The reasons for receiving no MMT included long distance journey (289, 48.8%), fear of exposure (124, 20.9%), poor daily medication compliance (59, 10.0%), fear of side effects (47, 7.9%), others (73, 12.3%). Conclusions The proportion of receiving no MMT in IDUs with AIDS in Dehong was high. Being female and farmer, in Jingpo ethnic group, low educational level, short diagnosed HIV infection history were influencing factors for receiving no MMT. The effective intervention measures should be taken to further improve MMT coverage according to the different characteristics of the patients.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close